Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DPR000047

Drug Information
NameFR-79620
SynonymsCID10421577; 3-(5-methyl-2-phenyl-1H-imidazol-4-yl)pyridine; CHEBI:101543; FR-79620; CHEMBL6893
CompanyFujisawa
IndicationEating disorder, Obesity, Diabetes
[ICD9: 250, 278, 307.5   ICD10: E08-E13, E66, F50]
Preclinical    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C15H13N3/c1-11-14(13-8-5-9-16-10-13)18-15(17-11)12-6-3-2-4-7-1
2/h2-10H,1H3,(H,17,18)
InChIKeyCAQAIFUDUGDPFB-UHFFFAOYSA-N
Canonical SMILESCC1=C(N=C(N1)C2=CC=CC=C2)C3=CN=CC=C3    
PubChem Compound IDCID 10421577.
PubChem Substance IDSID 15440049.
TargetNeuropeptide Y receptor type 5Antagonist[1]
Ref 1Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines. Expert Opin Emerg Drugs. 2005 Aug;10(3):643-60. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543